Pharmaceutical Insights

02 December 2008

Welcome to the December edition of Pharma Insights. In this edition, we consider the legal pitfalls faced by pharmaceutical manufacturers in developing and implementing marketing strategies, particularly in light of the trend towards greater transparency of their relationships with healthcare professionals.

We also consider how Australia compares with the EU when it comes to product liability claims, and the Government's moves to achieve cost recovery arrangements for PBS-listed medicines and vaccines.

Product liability and class actions: Pharma and medical devices in the litigation league table

By Jocelyn Kellam.

Product liability class actions have become a prominent feature of both the Australian legal landscape and the Australian public's view of the law as reflected in the media. Jocelyn Kellam reviews the statistics for class actions and product liability actions in Australia, the US and Europe.

Regulation and reputation: The legal pitfalls

By Greg Williams.

Greg Williams examines the trend towards increased regulatory scrutiny of marketing practices in the pharmaceutical industry and looks at how manufacturers can reduce the relevant risks.
Key Contacts

To view claytonutz.com correctly, you should upgrade your browser

Download Google Chrome
Download Firefox
Download Safari
Download Internet Explorer